Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REBECCA-2 Study
NCT06120595Active, not recruiting
- Sponsor
- Stavanger University Hospital
- Start
- Nov 2022
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Stavanger University Hospital. Primary endpoint: Quality of life (QoL) measured by the SF36-questionnaire at 24 months. Started Nov 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06120595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120595.